APA (7th ed.) Citation

Detke, H. C., Goadsby, P. J., Wang, S., Friedman, D. I., Selzler, K. J., & Aurora, S. K. (2018). Galcanezumab in chronic migraine: The randomized, double-blind, placebo-controlled REGAIN study. Neurology, 91(24), e2211. https://doi.org/10.1212/WNL.0000000000006640

Chicago Style (17th ed.) Citation

Detke, Holland C., Peter J. Goadsby, Shufang Wang, Deborah I. Friedman, Katherine J. Selzler, and Sheena K. Aurora. "Galcanezumab in Chronic Migraine: The Randomized, Double-blind, Placebo-controlled REGAIN Study." Neurology 91, no. 24 (2018): e2211. https://doi.org/10.1212/WNL.0000000000006640.

MLA (9th ed.) Citation

Detke, Holland C., et al. "Galcanezumab in Chronic Migraine: The Randomized, Double-blind, Placebo-controlled REGAIN Study." Neurology, vol. 91, no. 24, 2018, p. e2211, https://doi.org/10.1212/WNL.0000000000006640.